This article is a correction to:
A heterozygous mutation in NOTCH3 in a Chinese family with CADASIL
Juyi Li1†
Tao Luo2†
Xiufang Wang3†Mengjie Wang4†
Tao Zheng5Xiao Dang6
Aiping Deng1
Youzhi Zhang7
Sheng Ding4*Ping Jing2*
Lin Zhu8*- 1Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
- 2Department of Neurology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
- 3Department of Pain, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
- 4Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
- 5Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
- 6Department of Prenatal Diagnostic Center, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, China
- 7School of Pharmacy, Hubei University of Science and Technology, Xianning, China
- 8Department of Pediatrics, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China
A Corrigendum on
A heterozygous mutation in NOTCH3 in a Chinese family with CADASIL
by Li J, Luo T, Wang X, Wang M, Zheng T, Dang X, Deng A, Zhang Y, Ding S, Jing P and Zhu L (2022). Front. Genet. 13:943117. doi: 10.3389/fgene.2022.943117
In the published article, there was an error in the Funding statement. “A fund (Central Guiding Local Science and Technology Development Special Project, No. 2022BGE272) which supports our work was not included in the article.” The correct Funding statement appears below.
“This study was supported by the Health and Family Planning Commission of Wuhan City (WX18M02) and Central Guiding Local Science and Technology Development Special Project (No. 2022BGE272).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: CADASIL, whole-exome-sequencing, heterozygous, Notch3, treatment scheme
Citation: Li J, Luo T, Wang X, Wang M, Zheng T, Dang X, Deng A, Zhang Y, Ding S, Jing P and Zhu L (2023) Corrigendum: A heterozygous mutation in NOTCH3 in a Chinese family with CADASIL. Front. Genet. 14:1273023. doi: 10.3389/fgene.2023.1273023
Received: 05 August 2023; Accepted: 07 August 2023;
Published: 15 August 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Li, Luo, Wang, Wang, Zheng, Dang, Deng, Zhang, Ding, Jing and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sheng Ding, doctordingsheng@163.com; Ping Jing, jing51118@sina.com; Lin Zhu, zhulinhust@hust.edu.cn
†These authors have contributed equally to this work